Denali Advisors LLC Scholar Rock Holding Corp Transaction History

Denali Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 19, 2024	SELL	$6.52 - $20.32 $127,139 - $396,240	-19,500 Reduced 40.88%	28,200 $530,000
Q2 2023 Jul 18, 2023	BUY	$5.79 - $9.11 $252,444 - $397,196	43,600 Added 1063.41%	47,700 $359,000
Q1 2023 Apr 21, 2023	SELL	$7.36 - $12.72 $13,984 - $24,168	-1,900 Reduced 31.67%	4,100 $32,000
Q4 2022 Feb 09, 2023	SELL	$7.02 - $9.76 $21,060 - $29,280	-3,000 Reduced 33.33%	6,000 $54,000
Q3 2022 Oct 25, 2022	BUY	$5.33 - $11.3 $10,660 - $22,600	2,000 Added 28.57%	9,000 $62,000
Q2 2022 Jul 18, 2022	BUY	$4.66 - $13.96 $32,620 - $97,720	7,000 New	7,000 $38,000

175

75.6M

585K

862K

Ticker SRRK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,640,600
Market Cap $2.17B
Description
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...

Get notified when there are updates to the investment portfolio of Denali Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Denali Advisors LLC with notifications on news.